Our finding showed that the activation of PPAR-alpha by exogenous GH may also ameliorate NAFLD in rats without obvious side-effects, which suggested potential application value of GH in the prevention or reversal of fatty liver. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.